(Q46393651)

21 December 2017

title

CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture (English)

1 reference

21 December 2017

1 reference

Khaled Radad

1

1 reference

21 December 2017

Gabriele Gille

2

1 reference

21 December 2017

Jia Xiaojing

3

1 reference

21 December 2017

Nuria Durany

4

1 reference

21 December 2017

Wolf-Dieter Rausch

5

1 reference

21 December 2017

publication date

1 July 2007

1 reference

21 December 2017

International Journal of Neuroscience

published in

1 reference

21 December 2017

volume

117

1 reference

21 December 2017

issue

7

1 reference

21 December 2017

page(s)

985-998

1 reference

21 December 2017

Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disorders

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Effects of citicoline on phospholipid and glutathione levels in transient cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Citicoline: neuroprotective mechanisms in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Phospholipase A2, Hydroxyl Radicals, and Lipid Peroxidation in Transient Cerebral Ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

CDP-choline significantly restores phosphatidylcholine levels by differentially affecting phospholipase A2 and CTP: phosphocholine cytidylyltransferase after stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Neuroprotective effect of citicoline in 6-hydroxydopamine-lesioned rats and in 6-hydroxydopamine-treated SH-SY5Y human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Citicoline increases glutathione redox ratio and reduces caspase-3 activation and cell death in staurosporine-treated SH-SY5Y human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

A method for characterising cell death in vitro by combining propidium iodide staining with immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Chronic treatment with a precursor of cellular phosphatidylcholine ameliorates morphological and behavioral effects of aging in the mouse [correction of rat] hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Biochemical rationale for the use of CDPcholine in traumatic brain injury: pharmacokinetics of the orally administered drug.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Pharmacodynamics of citicoline relevant to the treatment of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Neuroprotection afforded by prior citicoline administration in experimental brain ischemia: effects on glutamate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Interactions among pathways for phosphatidylcholine metabolism, CTP synthesis and secretion through the Golgi apparatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

CDP-choline reduces pro-caspase and cleaved caspase-3 expression, nuclear DNA fragmentation, and specific PARP-cleaved products of caspase activation following middle cerebral artery occlusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Citicoline inhibits MAP kinase signalling pathways after focal cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Excitatory amino acids as a final common pathway for neurologic disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Effects of orally administered cytidine 5'-diphosphate choline on brain phospholipid content.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

"Brain-specific" nutrients: a memory cure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

CDP-choline prevents glutamate-mediated cell death in cerebellar granule neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Dietary CDP-choline supplementation prevents memory impairment caused by impoverished environmental conditions in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10623320600934341

10.1080/10623320600934341

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017